Since Reclast contains the same active ingredient as zoledronic acid (Zometa), patients treated with Zometa should not receive Reclast. Reclast group vs. 1.9%
preparation of this material, or the analysis of information provided in the material. Reclast and Zometa. Reclast for
Ibandronate (Boniva) and zoledronic acid (Reclast, Zometa) are bisphosphonates; denosumab (Prolia) is a monoclonal antibody.
Reclast and Zometa are two different brands of zoledronic acid. Reclast is used to treat osteoporosis caused by menopause, steroid use, or gonadal failure.
The intent of this policy/guideline is to provide information to the prescribing practitioner outlining the coverage criteria for Reclast, Zometa and
Bisphosphonates (such as Actonel, Atelvia, Boniva, Binosto, Fosamax, Reclast, or Zometa) are the most commonly prescribed treatment.
Examples of bisphosphonates are: Alendronate (Fosamax); Ibandronate (Boniva); Risendronate (Actonel); Zoledronic acid (Reclast Zometa)
Reclast, Zometa, others. Other names, zoledronate. AHFS/Drugs.com Monograph vs hospital bisphosphonate administration. British Journal of Cancer
Zoledronic acid (Reclast, Zometa) is a bisphosphonate. FDA Approved removed since tx interruption vs. hard stop; approval changed to 6 months
then vs than
accept vs expect
alright vs all right
its vs it's
there vs their
waist vs waste
your vs you're, you are